Biotechnology News

August 14, 2012

AARHUS, Denmark--(BUSINESS WIRE)--Today CLC bio has introduced a reduced price of $79 for CLC Main Workbench for students. The license is a stand-alone license for a single computer and is valid for 12 months from the time of purchase. The $79...

August 13, 2012

WASHINGTON--(BUSINESS WIRE)--Press Kit Materials are Available at: http://www.tradeshownews.com/events/BIO...

August 13, 2012

MIAMI--(BUSINESS WIRE)--ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended June 30, 2012. Kevin D. Clark, Chief Executive Officer, Chief Operating Officer...

August 13, 2012

WASHINGTON--(BUSINESS WIRE)--Press Kit Materials are Available at: http://www.tradeshownews.com/events/BIO...

August 13, 2012

SAN FRANCISCO--(BUSINESS WIRE)--ClinStar Director Business Development Michael Sullivan to Co-Lead Pre-Conference Workshop at Marcus Evans 7th Annual Clinical Research in Emerging Countries Conference

August 13, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) reported financial results for the second quarter of fiscal 2012.

August 13, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) announced that it has completed its previously announced underwritten public offering of its common stock at a price of $9.75 per share to the public.

August 13, 2012

BUENA, N.J.--(BUSINESS WIRE)--IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based topical generic drug development and manufacturing company, provided its financial results for the second quarter ended June 30, 2012. Second Quarter 2012...

August 13, 2012

BETHESDA, Md.--(BUSINESS WIRE)--MedImmune’s Peter Greenleaf, Clovis Oncology’s Patrick Mahaffy to Deliver Keynotes at 2012 Mid-Atlantic Bio Conference, September 27-28, 2012

August 13, 2012

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that physicians at all of the 17 “Honor Roll” hospitals and all of the 50 “Best Cardiology and Heart...

August 13, 2012

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Manhattan Scientifics (OTCBB:MHTX) announced today that it has achieved several critical milestones in the development of its proprietary technology for the early detection and treatment of cancer. Manhattan...

August 13, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics (NYSE MKT: IMUC) a clinical stage biotechnology company that is focused on developing new immune-based products to treat cancer, announced today that it was featured on CNN’s Sanjay Gupta...

August 13, 2012

SALT LAKE CITY--(BUSINESS WIRE)--A study published in the August issue of Journal of Clinical Microbiology showed that Great Basin Corporation’s toxigenic Clostridium difficile (C. diff) molecular diagnostic test has a 97 percent sensitivity and...

August 13, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--To help improve drug development, Quintiles has acquired Expression Analysis, a premier provider of genomics testing and analysis to biopharma, academic, government and non-profit customers.

August 13, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. to Present at the Wedbush PacGrow Life Sciences Management Access Conference.

August 13, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--To help dialysis patients enjoy flavorful, healthy meals, Fresenius Medical Care has partnered with Chef Aaron McCargo, Jr., and together they developed a list of helpful summer eating tips.

August 13, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical to meet global public health challenges is pleased to announce the initiation of GMP development plan for CS-TATI-1...

August 13, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of Biopump™, a novel technology for the sustained production and delivery of therapeutic proteins in...

August 13, 2012

BOSTON & GENEVA--(BUSINESS WIRE)--Global ePRO leader PHT Corp. launched the PHT Integration Engine, a product that enables clinical study sponsors and CROs to integrate multiple data streams in real time.

August 13, 2012

PARSIPPANY, N.J.--(BUSINESS WIRE)--Contract Research Organization DSP Clinical announced that President and Founder Darlene Panzitta is among this year’s PharmaVOICE 100 most influential people in life sciences.

August 13, 2012

DIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO® 3 MEM (Multi-Electrode Mapping) Version in the United States.

August 13, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Sequenta, Inc. and the Eastern Cooperative Oncology Group today announced an agreement to use Sequenta’s LymphoSIGHT™ next-generation sequencing method for the measurement of MRD in a clinical trial.

August 13, 2012

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical’s ongoing Zilver® PTX® trial data show higher freedom from target lesion revascularization (TLR) rates after three years

August 13, 2012

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc., today announced a reminder that its annual general meeting and corporate update will be on September 13, 2012 at 10:00 a.m. eastern. The meeting will held at the Fibrocell Science headquarters...

August 13, 2012

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTC: BCLI), a leading developer of adult stem cell technologies and CNS therapeutics, announced that Rasheda Ali Walsh, daughter of the legendary Muhammad Ali,...

August 13, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for patient lifts and lateral transfer devices

August 13, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV) (“InSite”) today announced that Merck & Co., Inc., through its subsidiary Inspire Pharmaceuticals, Inc. (“Merck”), has agreed to amend the payment terms of the...

August 13, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) announced today the results from the completed non-clinical study of SNS01-T in combination of lenalidomide in a model of multiple myeloma...

August 13, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc., a company developing Tcelna™, today reported financial results for the quarter ended June 30, 2012 and provided an overview of recent corporate developments.

August 13, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has received a communication from...

August 13, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Sirona Dental Systems (Nasdaq: SIRO), the company that pioneered digital dentistry more than 27 years ago and the global number one producer of dental CAD/CAM systems, will celebrate the 27 and a half year...

August 13, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences, an innovative developer of molecular diagnostic tests, announced today that the company will present at the NGx: Applying Next-Generation Sequencing Conference in Providence, RI on...

August 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem announces second quarter 2012 financial results.

August 13, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced top line results from a post-marketing commitment study evaluating a 5mg dose of dalfampridine-ER to improve walking in people with multiple sclerosis (MS)....

August 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, announced today that one of the company’s neurosurgeons,...

August 13, 2012

TOKYO--(BUSINESS WIRE)--The BioJapan Organizing Committee and ICS Convention Design, Inc. are pleased to present BioJapan 2012- The 14th annual event- for three days from October 10 to 12 at Pacifico Yokohama, Japan. Yokohama is a port city in...

August 13, 2012

DUBLIN--(BUSINESS WIRE)--Elan to Spin-Off Discovery Science & Neotope Business to Shareholders

August 10, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported its financial results for the second quarter and first six...

August 10, 2012

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) (“Forest”) today issued the following open letter to all Forest shareholders. Forest’s Board of Directors continues to recommend that shareholders vote for all 10 of the Company’s...

August 10, 2012

WASHINGTON--(BUSINESS WIRE)--The Renewable Fuel Standard (RFS) sets a path for U.S. energy security, reduced reliance on foreign oil and a cleaner environment; and it’s working said the Biotechnology Industry Organization (BIO) today in response...

August 10, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that Lucentis® (ranibizumab injection) was approved by the U.S. Food & Drug Administration (FDA) for treatment...

August 10, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical to meet global public health challenge and over-the-counter cosmetic and nutraceutical products with their associated...

August 10, 2012

SANTA ROSA, Calif.--(BUSINESS WIRE)--Sapheon Inc. announced one year data in a 38-patient clinical study of the VenaSeal™ Sapheon® Closure System, an advanced approach to the treatment of saphenous vein disease based on a proprietary medical...

August 10, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for patient warming products

August 10, 2012

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc. (“Lantheus”) today announced that it will host a conference call at 4:00 p.m. ET on Thursday, August 16, 2012 to discuss its financial and operating results for the second...

August 10, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL® (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-...

August 10, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (NASDAQ: CLDX) today reported financial results for the second quarter ended June 30, 2012. Celldex reported a net loss of $13.8 million, or $0.23 per share, for the second quarter of...

August 10, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III AVAglio study of Avastin® (bevacizumab) plus radiation and temozolomide chemotherapy in people...